Koev G, Mondal R, Beyer J, T. Reisch, S. Masse,W. Kati, D. Hutchinson, C. Flentge, J. Randolph, P. . Characterization of resistance mutations selected in vitro by the non-nucleoside HCV polymerase inhi. Annual Meeting of the European Association fo. 2009. 953. p. S346. Find at Google Scholar.
Bartels DJ, Sullivan JC, Zhang EZ, Tigges AM, Dorrian JL, De Meyer S, Takemoto D, Dondero E, Kwong A. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely. J Virol. . 2013. 87(3). 1544-1553. Find at Google Scholar.
Middleton T, He Y, Beyer J, Menon R, Klein C, Cohen D, Collins C. . Resistance profile of ABT-333 and relationship to viral load decrease in patients treated in combina. J. Hepatol. . 2010. 52. S296-S297. Find at Google Scholar.
Sun SC, Bae A, Qi X, Harris J, Wong KA, Miller MD, Mo H. . Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naive HCV patient. J Viral Hepat. . 2011. 18(12) . 861-870. Find at Google Scholar.